AU2001229646A1 - Method of identifying the function of a test agent - Google Patents

Method of identifying the function of a test agent

Info

Publication number
AU2001229646A1
AU2001229646A1 AU2001229646A AU2964601A AU2001229646A1 AU 2001229646 A1 AU2001229646 A1 AU 2001229646A1 AU 2001229646 A AU2001229646 A AU 2001229646A AU 2964601 A AU2964601 A AU 2964601A AU 2001229646 A1 AU2001229646 A1 AU 2001229646A1
Authority
AU
Australia
Prior art keywords
identifying
function
test agent
test
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229646A
Inventor
Stacey A. Minskoff
Thomas J Powell
Kerry E. Quinn
Tennore Ramesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of AU2001229646A1 publication Critical patent/AU2001229646A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
AU2001229646A 2000-01-21 2001-01-19 Method of identifying the function of a test agent Abandoned AU2001229646A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17741600P 2000-01-21 2000-01-21
US60177416 2000-01-21
USNOTGIVEN 2000-12-07
PCT/US2001/001838 WO2001053534A2 (en) 2000-01-21 2001-01-19 Method of identifying the function of a test agent

Publications (1)

Publication Number Publication Date
AU2001229646A1 true AU2001229646A1 (en) 2001-07-31

Family

ID=22648513

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229646A Abandoned AU2001229646A1 (en) 2000-01-21 2001-01-19 Method of identifying the function of a test agent

Country Status (3)

Country Link
US (1) US20010046665A1 (en)
AU (1) AU2001229646A1 (en)
WO (1) WO2001053534A2 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852004T2 (en) * 1987-04-15 1995-06-01 Yissum Res Dev Co METHOD FOR DETERMINING THE EXPRESSION OF BIOREGULATORY GENES IN MICROCULTURES OF EUCARIONTIC CELLS.
EP0534640B1 (en) * 1991-09-23 1996-10-02 Pfizer Inc. Process for detecting specific mRNA and DNA in cells
US5985829A (en) * 1994-12-19 1999-11-16 The United States Of America As Represented By The Department Of Health And Human Services Screening assays for compounds that cause apoptosis and related compounds
US5955269A (en) * 1996-06-20 1999-09-21 Rutgers, The State University Of New Jersey Methods of screening foods for nutraceuticals
US5804436A (en) * 1996-08-02 1998-09-08 Axiom Biotechnologies, Inc. Apparatus and method for real-time measurement of cellular response
US6008014A (en) * 1996-09-04 1999-12-28 Millennium Pharmaceuticals, Inc. Method of making lipid metabolic pathway compositions
WO1999050401A1 (en) * 1998-03-27 1999-10-07 Helix Research Institute Method for detecting change in gene expression by treating with test compound
US6146830A (en) * 1998-09-23 2000-11-14 Rosetta Inpharmatics, Inc. Method for determining the presence of a number of primary targets of a drug
US6479241B1 (en) * 1999-09-10 2002-11-12 Southern Research Institute High throughput screening of the effects of anti-cancer agents on expression of cancer related genes in various cell lines

Also Published As

Publication number Publication date
WO2001053534A3 (en) 2002-04-18
WO2001053534A2 (en) 2001-07-26
US20010046665A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2002212258A1 (en) Assembly and method for the optical-tactile measurement of a structure
AU2002232386A1 (en) A method for testing a light-emitting panel and the components therein
AU2002225956A1 (en) Automated test protocol
EP1154276B8 (en) Testing head for microstructures
AU2001263887A1 (en) Monitoring method
AU2001250686A1 (en) Method and device for testing a well
AUPQ886100A0 (en) Diagnostic test
AUPQ687600A0 (en) A method of detection
AU2001253917A1 (en) Fluid testing apparatus
AU2001282185A1 (en) Testing a transceiver
AU2001281633A1 (en) Detection method
AU2001275007A1 (en) Methods of testing materials
AU2002231295A1 (en) Developed seed and methods for making the same
AU2001254959A1 (en) Test signalling
AU3584101A (en) Test apparatus
AU2001272273A1 (en) Laser-ultrasonic testing system
AUPR050700A0 (en) Detection method
AU3717601A (en) Ultrasonic testing
AUPQ667800A0 (en) Detection method
AU2001278135A1 (en) Method of identifying immunosuppressive agents
AU2001237530A1 (en) Method
GB0012992D0 (en) Test method
AU2001236968A1 (en) Lssd interface
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2001241636A1 (en) Halotherapy method